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INTRODUCTION 
INTR O D U CTIO N
The third stage of labour commences after the delivery of the fetus / fetuses and ends with the 
delivery of the placenta and its membranes. In view of the maternal risks involved the third 
stage of labour forms the most important phase of parturition. Although it occupies a very short 
period  of  time  when compared  to  the  several  hours  devoted  to  labour,  this  crucial  period 
involves many hazards to the maternal life and health.
“Women are not dying because of a disease we cannot treat. They are dying because societies 
have yet to make the decision that their lives are worth saving”
- Fathalla, World Congress at Copenhagen, 1997.
Postpartum Hemorrhage is the most common cause of maternal mortality, and accounts for the 
25% of maternal deaths in our country. The optimal solution for the vaste majority, if not all, of 
these tragedies is prevention both before birth, by assuring that women are sufficiently healthy 
to withstand postpartum hemorrhage should it occur and at the time of birth, by the use of 
physiological (or) active management of third stage of labour.
The active management of third stage of labour, as approved by FIGO in 2003, acts prompt to 
time to combat postpartum haemorrhage, should it occur so that the valuable lives of pregnant 
mother can be saved in long way.
The  present  study  was  designed  to  evaluate  and  compare  the  efficacy  of  placental  blood 
drainage after spontaneous vaginal delivery as a part of active management of third stage of 
labour, versus no placental blood drainage done.
AIM OF THE STUDY 
AI M  O F  T H E  ST U D Y
1. To assess the effectiveness of placental Blood Drainage as a part of active management 
of third stage of labour.
2. To study the effectiveness of placental blood drainage in III stage critical events.
(i) Duration of III stage.
(ii) Blood loss of III stage.
(iii) Complications of III stage.
REVIEW   OF LITERATURE 
R E VIE W  O F  LITE R AT U R E
Signs of placental separation
1. The uterus becomes globular, and as a rule firmer. This is the earliest sign to appear. 
2. There is often a sudden gush of fresh blood.
3. The uterus rises in the abdomen because the placenta, having separated passes down into 
the lower uterine segment and vagina, where its bulk pushes the uterus upward.
4. The umbilical cord protrudes farther out of the vagina, indicating, that the placenta has 
descended.
These signs sometimes appear within about 1 minute after the delivery of newborn and usually 
within 5 minutes (William’s Obstetrics, 431 – 434).
Methods of placental separation: (Oxorn 5th edition)
There are two ways of placental separation of placenta.
 (1) Central separation (Schultze) 
Detachment of placenta from its uterine attachments starts at the centre resulting in opening up 
of  few  uterine  sinuses  and  accumulation  of  blood  behind  the  placenta  (retroplacental 
hematoma)  with  increasing  contraction,  more  and  more  detachment  occurs  facilitated  by 
weight of the placental and retroplacental blood until the whole placenta gets detached. 
(2) Marginal Separation (Mathew – Duncan)
Separation starts at the margin as it is mostly unsupported with progressive uterine contraction, 
more  and  more  areas  of  the  placenta  get  separated.  Marginal  separation  is  found  more 
frequently.
Physiological Mechanisms
Recognition of the physiological events taking place during normal labour is important in the 
correct  management  of  obstetric  complications.  At  term the  normal  volume of  blood flow 
through the placenta is 500-800 ml / minute. At placental separation, this has to be arrested 
within  seconds,  otherwise  serious  haemorrhage  will  occur.  There  are  three  inter  related 
physiological mechanisms for this:-
(i) Retraction of the oblique uterine muscle fibres in the upper uterine wall. This acts as a 
ligature to the torn blood vessels, which intertwine through the muscle.
(ii) Following  separation,  the  strong  uterine  contraction  brings  the  uterine  walls  into 
opposition, so that further pressure is exerted on the placental site.
(iii) There  is  evidence  to  support  that  there  is  transitory  increased  activation  of  the 
coagulation and fibrinolytic systems around the placental site so clot formation in the 
torn vessels is intensified. Following separation, the placental site is rapidly covered 
with fibrin mesh utilizing 5-10% of circulating fibrinogen. 
Following delivery of the infant, there is an immediate lowering of the uterine fundus due to so 
called retraction. This is facilitated by the typical arrangement of uterine circular muscle fibres. 
The retraction reduces the area of the uterine surface to which the relatively incompressible 
placenta is attached therefore separation occurs. 
Manual Removal of placenta
Adequate analgesia (or) anesthesia is mandatory. Aseptic surgical technique should be used. 
After  grasping  the  fundus  through  the  abdominal  wall  with  one  hand,  the  other  hand  is 
introduced into the vagina and passed into the uterus, along the umbilical cord. As soon as the 
placenta is reached, its margin is located and the ulnar border of the hand insinuated between it 
and the uterine wall. 
Then with the back of the hand, the placenta is peeled off its uterine attachment by gentle to 
and fro motion. After complete separation, the placenta is grasped with the entire hand and 
gradually withdrawn. The fundus of the uterus then palpated to note whether the uterus is well 
contracted. If not vigorous uterine massage with oxytocics administration is indicated. 
It  has been suggested that drainage of blood from the placenta would reduce its bulkiness, 
allowing the uterus to contract and retract and thus aiding delivery (Roger et al 1998).
Placental cord drainage may be used in conjunction with other interventions such as routine 
administration  of  oxytocic,  controlled  cord  traction  or  maternal  effort  (Hinchongbrooks 
Randomised controlled trial Lancet 1998).
Placental cord drainage with (or) without prophylactic oxytocics is effective in reducing the 
blood loss in III stage thus preventing postpartum haemorrhage (Keirse 1998).
Cord drainage was found to  have significant  benefits  in  reducing the  number of  placentas 
retained at 30mts after birth. The length of third stage of labour was also significantly shorter in 
the group who had cord drainage (Razmkhah et al 1999).
Timing at cord clamping is also an important factor in the management of third stage of labour; 
influences the duration of III stage (McDonald 2003).
Delayed  cord  clamping  in  preterm  infants  increased  the  risk  for  hyper  bilirubinemia  and 
increased the need for treatment with phototherapy – and lessens the incidence of RDS (Mercer 
2001).
Placental blood drainage is a simple, safe and non-invasive method which reduces the duration 
of blood loss in third stage thereby preventing postpartum haemorrhage. (Sharavage and Silpa 
2007).
Cochrane database of systematic reviews studied the effect of placental cord drainage on third 
stage of labour – selection of randomized trials  with cord drainage as a  variable,  result  in 
statistically significant reduction in the length of third stage of labour.
There are evidences to indicate that there are benefits in active management of third stage of 
labour, but it  may be associated with increased nausea, vomiting and raised blood pressure 
(Prendiville et al 2003).
Bristol  Third Stage Trial:  -  The active management of third stage of labour is effective in 
combating postpartum haemorrhage in a low-resource setting.
The need for blood transfusion was significantly less and the tendency towards an increase in 
the need for manual removal of placenta was noted in actively managed group (Roger et al 
1998).
Active versus Expectant Management
Prendiville  (2002)  summarized  the  five  major  trials  exploring  active  versus  expectant 
management in the Cochrane database of systematic reviews, aiming to determine which line 
of management is most likely to prevent post partum haemorrhage.
Routine active management was found to be superior in that there was a statistically significant 
reduction in 
(i) The incidence of moderate haemorrhage of 500 – 1000 ml.
(ii) Incidence of severe hemorrhage over 1000 ml.
(iii) Reduction on post partum maternal Hb < 9 gm/dl
(iv) Requirement of postnatal blood transfusion
(v) The need for therapeutic oxytocics. 
(vi) The duration of third stage lasting more than 20 minutes.
Women were more satisfied in the third stage if they had active management. 
Disadvantages
(i) The active management resulted in a statistically significant increase in the incidence of 
maternal diastolic BP greater than 100 mm of Hg.
(ii) Increase in maternal vomiting, nausea and headache post delivery. (Dublin Trial).
(iii) There is increased tendency towards manual removal of placenta. (Bristol III stage trial).
(iv) There is an increase in incidence of secondary PPH. (Bristol III Stage Trial)
The over all meta-analyses results of Cochrane database systematic reviews 2004, showed that 
there  was  a  tendency  for  the  active  management  group  to  have  higher  incidence  of  these 
complications  but  this  did  not  reach  statistical  significance.  There  was  no  statistically 
significant difference in neonatal outcome (or) breast feeding rates and no difference in long 
term maternal outcome.
ACTIVE MANAGEMENT  OF THE  THIRD 
STAGE   OF LABOUR
A CTIV E  M A N A G E M E N T  O F  T H E  
T HIR D  STA G E  O F  L A B O U R
Joint  statement of  the  international  conference of  midwives and International  federation of 
Gynaecology  and  Obstetrics  (FIGO)  –  November  2003  –  The  components  of  active 
management of third stage of labour are 
(i) Administration of uterotonic agents (Oxytocin when available is the drug of 
choice). 
(ii)  Early cord clamping 
(iii) Controlled cord traction 
(iv) Uterine massage after delivery of the placenta.
The  expectant  /  pure  physiological  management  involves  waiting  for  the  clinical  signs  of 
placental separation and allowing the placenta to deliver unaided using gravity (or) with the aid 
of nipple stimulation. (FOGSI, Special Edition – Postpartum Haemorrhage)
Uterotonics
Oxytocin
Synthetic cyclical nanopeptide stimulates the smooth muscle of the uterus, more powerfully 
towards the end of pregnancy, during labour and immediately postpartum. Oxytocin coupled to 
its receptors activates phospholipase C – that triggers the release of calcium from intracellular 
stores and thus leads to myometrial cell contraction. 
Oxytocin acts  rapidly,  latency period of  less  than 1min after  intravenous injection and 2-4 
minutes after intra muscular injection. When administered as infusion,  the uterine response 
begins  gradually  and  reaches  a  steady  state  within  20  –  40  minutes.  Prophylactic  use  of 
oxytocin had clear benefits in terms of postpartum haemorrhage (Cochrane Review, Elbourne 
et al)
Ergometrine
Naturally occurring ergot alkaloid stimulates the contractions of uterine and vascular smooth 
muscle.  It  increases the amplitude and frequency of uterine contractions and tone and thus 
impedes the blood flow. The vasoconstriction caused involves mainly the capacitance vessels, 
leading  to  an  increase  in  central  venous  pressure  and  blood  pressure.  It  produces  intense 
vasoconstriction by stimulation of v-adrenergic and serotonin receptors. 
It acts rapidly – the contractions are initiated within 1 minute after intra venous injection and 
lasts for upto 45 minutes, with the intra muscular injection the contractions are initiated within 
2-3 minutes and lasts for 3 hours or longer.
Ergometerine was associated with more manual  removal  of  the  placenta  (RR – 0.57,  95% 
confidence interval 0.41 – 0.79) and a statistically insignificant tendency towards hypertension 
(RR 0.53, 95% CI 0.19 – 1.58). 
Oxytocin agonists
Carbetocin  appears  to  be  the  most  promising  of  these  agents  in  preventing  postpartum 
haemorrhage. (Chong et al 2004).
Long acting synthetic octapeptide analogue of oxytocin, intramuscular injections of carbetocin 
provide similar responses to tetanic contractions (in 2 minutes), but with longer duration of 
activity.  Oxytocin agonists  for  the prevention of  postpartum haemorrhage are currently  the 
subject of additional review (Cochrane Review 2005).
Syntometrine
Syntometrine is a mixture of 5u of oxytocin and 0.5 mg of ergometrine maleate. A statistically 
significant lower rate of postpartum haemorrhage was observed with syntometrine regardless of 
the dose of oxytocin used (OR – 0.82) (The salford third stage trial – 1993).
The  use  of  syntometrine  was  associated  with  a  greater  rise  in  blood  pressure.  A  greater 
incidence  of  side  effects  was  noted  with  syntometrine  compared  to  oxytocin  alone.  The 
incidence of blood transfusion and manual removal of placenta was not statistically significant 
in two groups.
Prostaglandins
Prostaglandins ripen the cervix by altering the extracellular ground substance, by increasing the 
activity of collagenases and by increasing the elastase, glycosaminoglycans, dermatan sulphate 
and hyaluronic and levels in cervix. 
Misoprostol
Misoprostol is the synthetic analogue of naturally occurring PGE1. Rapidly absorbed following 
oral / vaginal administration and its bioavailability exceed 80%. Peak plasma levels are reached 
in 30-60 minutes and it is converted into active metabolite – misoprostol acid. The area under 
the misoprostol concentration Vs time curve is increased implying greater exposure time.
The studies have shown that oral misoprostol as a prophylactic agent for third stage of labour to 
be less effective at preventing postpartum haemorrhage than parenteral oxytocin. The more 
prolonged time interval required to achieve peak serum levels may make it a more suitable 
agent for protracted uterine bleeding.
Rectal misoprostol in a dose of 800 µg could be a useful first line drug for the treatment of 
primary  postpartum  haemorrhage.  Misoprostol  has  the  significant  advantage  of  low  cost, 
thermo stability,  light  stability  and lack of requirement for  sterile  needles and syringes for 
administration, makes it an attractive option for use in the developing countries. It has a shelf 
life of several years. (Cochrane Review – 2005)
Early Cord Clamping
In the active management of the third stage of labour, early cord damping is carried out in the 
first  30  seconds  after  birth,  regardless  of  the  presence  (or)  absence  of  cord  pulsations 
(McDonald 1996). The duration of third stage is reduced by cord clamping (Enkin 1995).
Late cord clamping constitutes expectant management, wherein clamping is deferred until the 
cord pulsations have ceased. Delayed clamping facilitates placental transfusion. This results in 
an increase in infant blood volume by 30% and an increase in hematocrit and Hb levels – hence 
less anemia in infancy. However it is short lived, effect lasts no longer than 6 months – A delay 
of cord clamping of as little as 30 seconds while holding the baby below the level of placenta, 
may therefore be an advantage in theory (Mercer 2001).
Controlled Cord traction (Brandt Andrews Method)
 Clamp the cord close to the perineum and hold in the right hand.
 The other hand is placed just above the pubic symphysis and the uterus is stabilized 
by applying the counter – pressure during controlled cord traction.
 Slight tension kept on the cord and the strong uterine contraction is awaited for. 
 With the  strong uterine  contraction,  the  mother  is  encouraged to  push  and very 
gently downward pull on the cord is applied to deliver the placenta.
 If the placenta does not descend during 30-40 seconds of controlled cord traction, 
stop pulling on the cord and wait for the next uterine contraction. Controlled traction 
on the cord repeated.
 As the placenta is delivered, it is held in two hands and gently turned round until the 
membranes are twisted. 
 If the membranes are about to tear / torn, the cervix and upper vagina are examined 
to remove any pieces of membrane that are present.
 The placenta  is  examined carefully  for  its  entirety.  If  a  portion  of  the  maternal 
surface is missing or there are torn membranes with vessels,  retained placenta is 
suspected and appropriate action is instituted. 
POSTPARTUM HAEMORRHAGE 
P OSTP A RT U M  H A E M O R R H A G E :
Postpartum haemorrhage was defined by WHO in 1990 as any blood loss from the genital tract 
during delivery above 500 ml. 
Two Varieties
Early / Primary PPH
Haemorrhage in the first 24 hours of vaginal delivery in excess of 500 ml is designated as 
Primary PPH.
Late / Secondary PPH
Haemorrhage that occurs any time after wards upto six weeks after delivery of the baby is 
designated as Secondary PPH.
Globally worldwide, PPH, is the major killer of maternal lives, accounting for 25% of maternal 
deaths.
Causes of primary PPH
The broad basic 4 ‘T’s of primary PPH are 
Tonus (Uterine atony)
Tissue
Trauma
Thrombin
Uterine Atony
Uterine atony accounts for about 80% of the cases of primary PPH. A soft boggy uterus on 
palpation with uterine bleeding after the delivery of the infant and placenta is characteristic of 
uterine atony.
Predisposing factors includes
1. Uterine over distention - Multiparity
Polyhydramnios
Macrosomia
2. Prolonged II stage.
3. Precipitate labour.
4. Antepartum Haemorrhage.
5. Presence of uterine fibroids especially intramural / submucous fibroids.
6. Presence of uterine abnormalities. 
7. Chorioammonitis.
8. Excessive /prolonged use of oxytocics in labour.
9. Use of halogenated anaesthetics.
10. Use of Magsulf, nifedipine, betamimetics. 
Tissue 10%
1. Placental abnormalities – placenta accreta,  succenturiate lobe. 
2. Prior uterine surgery.
3. Excessive traction on cord.
4. Retained placenta
Trauma 20%
Episiotomy / Cervical tears.
Vulvovaginal injury
Uterine rupture 
Inversion of uterus. 
Thrombin 5%
Acquired Coagulopathies - HELLP syndrome
DIC – Eclampsia 
Intrauterine fetal death
Septicaemia
Abruptio placentae
Amniotic fluid embolism
Anti coagulant therapy
Congenital – Von wille brand’s disease
 ITP
Measurement of Blood loss
Accurate measurement of blood loss at delivery is necessary as a means of early detection of 
postpartum haemorrhage. Visual assessment of blood loss in the presence of a contracted uterus 
may diagnose traumatic PPH late and therefore result in delayed referrals. The blood let down 
from the unclamped cord is collected separately and discarded. The mops used for episiotomy 
are discarded separately after weighing. The blood from the genital tract is let to collect into 
clean metal bowl placed in between the women’s thighs and left in place to collect the blood 
loss over the next few minutes. 
Blood and clots  from the metal  bowl are measured in  measuring cylinder.  Blood loss was 
calculated as 1g = 1ml (Harding 1984). This gives only the approximate blood loss during the 
third stage.
Blood clot of the size of a fist is roughly equal to 500 ml clinically.
Clinical signs and symptoms pertaining to blood loss
Blood loss (% 
volume lost)
10 – 15% 15 – 30% 30 – 40% > 40%
Consciousness Alert, mild 
thirst
Anxious restless Confused 
agitated
drowsy 
unconscious
Respiratory rate normal mildly elevated raised raised 
Pulse rate normal normal elevated fast & thready
systolic blood 
pressure
normal normal slightly  low 
80mm Hg
< 60 mm Hg
Extremities normal cool pale & cool cold
Capillary refill normal slow (>2sec) Slow (>2 sec) absent
Urine output normal reduced reduced obigoanuric 
(Source : Baskett, BMJ, 1990 300: 1453 – 1457).
Treatment
Most maternal deaths in PPH are due to THE THREE DELAYS 
1. Delay in recognition of complications:
a. Under estimation of blood loss – the women already hypovolemic, are not afford 
to loss 500 ml to label as PPH. Individualise the treatment.
b. Inadequate volume replacement.
2. Delay in institution of definitive management
3. Delay in referral / accessing transportation.  
Management:
General
Specific – Medical
Surgical
General Management
1. Assessment of general condition of the patient, the amount of blood loss and degree of 
hypoxaemia.
2. Vital parameters recorded – level of consciousness, pulse rate, respiratory rate, blood 
pressure, degree of pallor, urine output continuous bladder drainage.
3. 100% oxygenation by face mask.
4. Two large bore peripheral intravenous access secured.
5. Blood sent for complete blood count, RFT & cross matching.
6. Crystalloid  &  colloids  rushed  in  the  meantime.  It  enhances  the  atrial  filling  and 
improves  the  cardiac  output.  250  –  500  ml  of  either  a  crystalloid  or  a  colloid  is 
administrated over a period of 10 – 20 minutes as the urgency indicates. Crystalloids are 
preferred over colloids as they quickly become distributed throughout the extracellular 
space; cheap; easily available; no risk of anaphylaxis.
7. Replace the blood loss which is calculated by visual means according to the loss and by 
percentage of blood loss in body volume.
8. Invasive hemodynamic monitoring – central venous pressure measurement via jugular 
approach – for accurate measurement of fluid balance where feasible.
9. Bleeding  time  and  clotting  time  to  be  monitored  at  the  patient’s  bed  side  –  when 
prolonged; to be treated with fresh frozen plasma, cryoprecipitate.
10. Once the patient is stabilized, a quick P/A, per vaginal examination to be done to assess 
the cause for PPH.
11. Bimanual compression of the uterus prevents an increase in the radius of the uterus due 
to bleeding in the uterus. Simultaneously the uterus is pushed cephalad, which puts the 
uterus under tension and reduces the blood flow to the uterus.
Medical Management 
Uterotonic agents in PPH – in atonicity of the uterus
Agent Dose Route of 
Administration
Side effects
Oxytocin 10u/im/iv followed 
by 20 iv infusion in 
500ml RL/NS 
crystalloid titrated 
versus response.
Intravenous Hypotension  if  given  by 
rapid  iv  Bolus.  Water 
intoxication  with  larger 
volumes. 
Methyl 
ergometrine
0.2 mg 6th hourly Intramuscular  / 
Intravenous
Vasoconstriction – in creased 
blood  pressure,  head  ache, 
nausea, vomiting.
Misoprostol Vaginal, rectal oral 400 – 1000 µg GI  disturbances,  shivering, 
pyrexia
15Methyl 
PGF2α
IM/Intra myometrial 0.25  mg  can  be 
repeated every 15 
mts. max 2 mg
bronchospasm
Tranexamic 
Acid
IV 1g 8th Hourly can  increase  the  risk  of 
thrombosis
Recombinant 
factor VII a
IV 60 – 120 µg / kg Fever, hypertension.
Surgical Management of PPH
Surgical Management of PPH has traditionally relied on hysterectomy and ligation of internal 
liac arteries but over the last few years a number of new and simple techniques have come into 
use prior to restoring to complex and risky major surgical procedures.
(i)Under suturing of placental bed – where PPH follows placenta praevia / low lying placenta 
the large sinuses may not effectively retract,  under  sewing the uterine cavity  can be done, 
taking care not to obliterate the cervical canal and the internal os (Arulkumaran 1999).
(ii) Balloon Tamponade -  A Sengstaken Blake more tube is inserted into the uterine cavity, 
the esophageal / stomach balloon is filled with 75-450 ml of saline until it just becomes visible 
at cervical canal.  If  the bleeding is controlled, upper vagina is packed with roller gauze to 
prevent expulsion of balloon, and the bladder catheterised. It can be left for a period of 24 
hours – Positive Tamponade Test.
Johnson et al (2001) described the use of urological. Rusch Hydrostatic balloon catheter to 
control intractable PPH.
(iii) Uterine BRACE Sutures: B Lynch  
B-Lynch  suturing  technique  involves  a  pair  of  vertical  brace  sutures  around  the  uterus 
essentially to oppose the anterior and posterior walls and to apply continuing compression.
(iv) Multiple square suturing techniques: Chos
These brace sutures work by direct application of pressure on the placental bed bleeding and 
also by reducing blood flow to the uterus. Four or five square sutures are placed evenly from 
the fundus through to the lower segment of the uterus. The advantage is that it is technically 
easy to perform and requires a short operating time.
(v) Stepwise devascularisation of the uterus: MAL ABDRABOS
Uterine artery is identified at the base of broad ligament at (or) just below the level of UV 
peritoneal reflection
Ligation of utero ovarian anastamosis near the ovarian ligament after the branch to the round 
ligament.
(vi) Internal Iliac Artery ligation :
Bilateral  Internal  iliac  artery ligation results  in 85% reduction in  the pulse  pressure  in  the 
arteries distal to the ligation and the blood flow by 50% in the distal  vessels – turning an 
arterial pressure system into the one with pressures approaching that in the venous system. 
Internal iliac artery is ligated after the posterior branch has formed.  
(vii) Uterine Artery Embolisation :
Under LA and fluoroscopic control, the catheter is advanced above the bifurcation of the aorta 
and the bleeding point is identified by contrast injection. The feeding artery is catheterized and 
embolised with polyvinyl alcohol particles, which will be reabsorbed in ten days.
(viii) Hysterectomy :
Reserved where all other avenues available have been exhausted, but bleeding continues with a 
severely shocked patient. 
MATERIALS AND METHODS
M A T E RIA LS A N D  M E T H O DS
The Study was conducted at Government Rajaji Hospital, Madurai from September 2007 to 
September 2008.
200  patients  with  pregnancy  at  or  beyond  37  weeks  with  a  single  live  fetus  in  cephalic 
presentation who had a spontaneous vaginal delivery were included in the study.
It was a prospective comparative evaluation of two groups –the study group consisted of 100 
patients - in whom the placental blood was drained. The rest of the 100 patients were placed as 
controls where the cord blood was not drained.
Group – A (Study) 100 patients -     Placental Blood was drained.
Group – B (control) 100 patients   -     Placental Blood was not  drained
Inclusion criteria
1. Singleton pregnancy
2. Vertex presentation
3. Gestational Age of 37 weeks (or) more.
4. No major medical (or) obstetric complications.
5. Spontaneous vaginal delivery
Exclusion Criteria
1. HB % < 7 gm / dl
2. History of APH
3. Instrumental delivery
4. Multiple pregnancy
5. Malpresentations
6. Large Baby (more than 3.5 kg )
7. Polyhydramnios
8. Known coagulations disorders
9. Previous surgeries on the uterus.
Procedure
After a detailed History taking including complications of present pregnancy, general physical 
examination & obstetric examinations were made.
Gestational age was confirmed by menstrual history, clinical examination and ultrasound. 
Routine Hematological and urine examinations were done
All women were monitored carefully through the first and the second stages of labour with vital 
parameters and fetal heart rate.
Those with ineffective uterine contractions received augmentation with oxytocin as intravenous 
infusion or ARM or a combination of these as per the individual needs. Induction of labour 
where necessary, was done with PGE2 gel.
All the patients in the study group were counseled regarding the procedure of cord drainage and 
an  informed  consent  was  obtained.  Immediately  after  spontaneous  vaginal  delivery,  after 
clamping and cutting the cord- the cord was unclamped and the blood was drained until the 
flow ceased.
Prophylactic oxytocic- intravenous methergine 0.2 mg for active management of the III stage 
of labour was given.
In the control group, the clamped cord was not released. 
After  the  signs  for  placental  separation  appeared,  the  placenta  was  delivered  by  Brandt- 
Andrews method of controlled cord traction in the both the groups. 
Blood lost in the third stage of labour was measured by collecting the blood in a clean metal 
bowl taking care, that the blood from episiotomy wound did not get mixed with the uterine 
loss. If there was excessive bleeding due to uterine atony, appropriate measures were instituted.
The mops used for episiotomy were separated & discarded. The duration of the third stage was 
calculated using a stop watch.
Once the uterus was well contracted and the active bleeding had stopped, the remaining blood 
in the vagina was removed and a sterile sanitary pad was given.
The blood collected in the metal bowl was measured using a measuring jar. 
The pulse rate, blood pressure and the state of uterus were noted immediately after delivery.
The women were kept under observation for the next two hours to watch for complications if 
any.
Blood transfusion was given whenever the blood loss was more than 1000 ml (or) if indicated 
by the clinical status of the patient. Blood Hb% was measured after 48 hours of delivery in both 
the groups and difference from that of the antenatal value was observed.
The patients were carefully watched in the post natal ward for 48 hours for any morbidity.
RESULTS
R ES U LTS
Profile of cases studied
Table 1 
Age Distribution
Age group Study Cases ControlsNo. % No. %
Less than 20 years 11 11 6 6
20-24 years 57 57 72 72
25-29 years 28 28 17 17
30 years & above 4 4 5 5
Total 100 100 100 100
Mean
S.D.
23.05 yrs
3.11 yrs
22.72 yrs
2.87 yrs
‘p’
0.3981
Not significant
Comparing the age distribution in both the groups, 85% (85/100) of the patients in the study 
group and 89% (89/100) of the patients in the control group were in the age group of 20 – 29 
years  Teenage patients  were 11% in group A & 6% in group B.  4% (4/100) in the  study 
population and 5% (5/100) in the control population were in the age group of 30 years and 
above. There was no significant difference in the mean age of the patients in both the groups.
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Table 2
Antenatal care
Antenatal Care Study Cases ControlsNo. % No. %
Booked 79 79 83 83
Unbooked 21 21 17 17
‘p’
0.5887
Not significant
In the study group – 79% (79/100) were booked cases and had atleast five antenatal check ups 
and the rest were unbooked cases. 
In the control group – 83% (83/100) were booked cases and the rest were unbooked cases.
The antenatal care received by the two groups did not exhibit statistically significant difference.
Table 3
Parity
Parity
Study Cases Controls
No. % No. %
Booked 63 63 46 46
Unbooked 37 37 34 34
‘p’
0.7676
Not significant
In the study group- 68% (68/100) were primigravidae, the rest were multigravidae.
In the control group – 66% (66/100) were primigravidae, the rest were multigravidae.
The parity of the two groups did not show any significance. 
 PARITY
63
37
66
34
0
10
20
30
40
50
60
70
STUDY
CASES
CONTROLS
PRIMI MULTI
Table 4
Period of Gestation
Gestation
(in weeks) Study Cases Controls
Mean
S.D.
39.3
1.3
37.16
1.24
‘p’
0.1898
Not significant
Patients with term gestation (37- 42 weeks) were selected for the study.
In the study group, the mean gestational age was 39.3 weeks and in the control group, it was 
39.16 weeks.
The period of gestation in the two groups did not differ significantly.
Table 5
Quantitative parameters
Parameters Study Cases ControlsMean S.D Mean S. D P Value
Height ( in cms) 152.5 3.6 151.6 3.4
0.0665
Not significant
Weight ( in kgs) 57.62 3.07 58.55 6.08
0.4615
Not significant
B.M.I. 24.83 1.72 25.46 2.31
0.0732
Not significant
The mean height and the weight of the patients were 152.5 cms and 57.62 kg respectively in the 
study group, 151.6 cms and 58.55 kg in the control group. The mean BMI was 24.83 in the 
study group and 25.46 in the control group. 
The two groups did not differ statistically in terms of height, weight & BMI.
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Table 6
Interventions
Intervention
Study Cases Controls
No. % No. %
Induction of labour 22 22 23 23
Acceleration of labour 48 48 56 56
Spontaneous labour 30 30 21 21
TOTAL INTERVENTIONS 70 70 79 79
NO INTERVENTIONS 30 30 21 21
‘p’
0.1943
Not significant
In the study group, 30% (30/100) had spontaneous onset of labour and in the control group, it 
was 21% (21/100).
The labour was induced with PGE2 gel in 22% (22/100) of the patients in the study group. In 
the control group it was 23% (23/100).
The labour was accelerated for ineffective uterine contractions in 48% (48/100) in the study 
group and in 56% (56/100) of the patients in the control group.
No interventions were used for 30% in study group & 21% in control group.
The mode of interventions did not differ statistically in both the groups.
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Table 7
Birth Weight
Birth Weight
(in kg)
Study Cases Controls
Mean
S.D.
2.84
0.29
2.88
0.31
‘p’
0.4115
Not significant
The mean birth of the baby in study group was 2.84 kg and that in the control group was 2.88 
kg.
The both groups were comparative, without any significance.
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Table 8
Mean Duration of III stage of Labour
Duration of III stage 
in seconds
Study Cases Controls
Mean
S.D.
210.5
143.4
318.5
83.8
‘p’
0.0001
Significant
In the study group, the mean duration of third stage of labour was 210.5 seconds (3.5 minutes).
In the control group,, the mean duration of III stage is 318.5 seconds (5.3 minutes).
‘p’ value was 0.0001- the result being statistically significant.
DURATION OF III STAGE OF LABOR
(in seconds)
210.5
318.5
0
50
100
150
200
250
300
350
D
U
R
A
TI
O
N
 (i
n
 s
ec
on
ds
)
STUDY
CASES
CONTROLS
Table 9
Blood loss
Blood loss in m1 Study Cases ControlsNo. % No. %
0-100 4 4 - -
101-200 45 45 13 13
201-300 38 38 47 47
301-400 9 9 27 27
401-500 2 2 3 3
Above 500 2 2 10 10
Total 100 100 100 100
Mean
S.D.
232.5
88.6
310.1
103.3
‘p’
0.0001
Significant
In group A 4 % had blood loss less than 100 ml.
In group B none had blood loss less than 100 ml.
49 % of group A patients had blood loss of less than 200 ml.
13% of group B patients had blood loss of less than 200 ml.
Upto 300 ml of Blood loss is noted in 87 % of patients in group A and   60% of patients 
in group B.
Only 13 % of patients in group A had blood loss of more than 300 ml.
The mean blood loss was 232.5 ml in group A.
The mean blood loss was 310.1ml in group B.
The result is statistically significant.
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Table 10
Post Partum Haemorrhage
Post Partum 
Hemorrhage
Study Cases Controls
No. % No. %
Yes 2 2 10 10
No 98 98 90 90
‘p’
0.0371
Significant
The incidence of post partum haemorrhage was calculated as a blood loss of more than 500ml 
in both the groups.
2% (2/100) of the study group and 10% (10/100) of the control group patients had post partum 
haemorrhage.
The incidence of post partum haemorrhage between the two groups was statistically significant.
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Table 11
Manual Removal of Placenta
Manual removal of 
placenta
Study Cases Controls
No. % No. %
Done 2 2 2 2
Not done 98 98 98 98
‘p’ -
2% (2/100) of  study group patients  and 2% (2/100) of the control  group patients  required 
manual removal of placenta. In all these cases placenta remained unseparated that was cleaved 
and removed in toto.
The incidence being similar in both the groups, there was no significance.
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Table 12
Blood Transfusion
Blood Transfusion
Study Cases Controls
No. % No. %
Given 5 5 6 6
Not given 95 95 94 94
‘p’
0.757
Not significant
The requirement of Blood transfusion was decided by the clinical status of the patient (or) if the 
blood loss was more than 100ml in both the control and the study groups. 
5% (5/100) of patients in the study group and 6% (6/100) of patients in the control  group 
required blood transfusion.
‘p’ value being 0.757, the result was not significant statistically. 
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Table 13
Changes in Hb%
Hb%
Study Cases Controls
Mean S.D. Mean S.D.
Before delivery 9.12 0.58 9.15 0.56
After delivery 8.74 0.65 8.55 0.68
Decrease in Hb.% 0.38 0.24 0.59 0.27
‘p’
0.0001
Significant
The  maternal  Hb% level  before  delivery  was  compared  with  changes  in  Hb% level  after 
delivery.
The mean decrease in Hb% was 0.38 gm/d1 in the study group whereas it was 0.6 gm/d1 in the 
control group.
The result was statistically significant.
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Statistical Tools 
The information collected regarding all the selected cases were recorded in a Master Chart. 
Data  analysis  was  done  with  the  help  of  computer  using  Epidemiological  Information 
Package (EPI 2002).
Using this software, frequencies, percentages, means, standard deviations, chi square and ‘p’ 
values were calculated.  Kruskul Wallis  chi-square test  was used to test  the significance of 
difference between quantitative variables and Yate’s test for qualitative variables. A ‘p’ value 
less than 0.05 is taken to denote significant relationship.
DISCUSSION
DISC USSIO N
Patients undergoing normal progression of labour can become abnormal within few minutes 
and even a successful delivery can turn swiftly into a disaster if post partum hemorrhage enters 
the scene.
As  the  saying  goes  “A  stitch  in  time  saves  nine”  prompt  recognition  and  appropriate 
management of third stage of labour and it’s complications should be done, or else it may even 
land up in maternal death in no time.
This study was conducted in the Department of obstetrics & Gynaecology, Government Rajaji 
Hospital, Madurai to study the efficacy of placental Blood Drainage versus none in patients 
with spontaneous vaginal delivery as a part of active management of III stage of labour.
In this study, of the placenta was drained by unclamping the previously clamped cord in 100 
patients. 
In another 100 patients, the cord was kept clamped and the placenta was not drained.
Discussion of Profile of cases studied
Age group and Patients selection
In  our  study,  the  age  group  of  patients  included  varied  between  18-32  years.  Maximum 
percentage of patients belonged to the age group of 20-24 years.
85% of the study group was between 20-29 years.
89% of the control group was between 20-29 years.
The mean age in both the groups was comparable.
In a similar randomized controlled trial by Giacalone et al, 2000, Great Britain-the mean age of 
patients who entered the study was 25 years and in a randomized controlled trial conducted at 
the Medical College Belgaum, Department of Obstetrics & Gynaecology by Shravage et al, the 
mean age of patients was 23 years.
Antenatal care
In our study, in both the study and the control groups, the proportion received antenatal care 
was greater than those who did not.
79% received antenatal care in the study group & 83% in the control group, ‘p’ valve being not 
significant.
Parity
In our study, the primigravidae were more in both the groups compared to the multi gravidae. 
All were singleton pregnancies. 
In the study group – 63% were primigravide ; 37% were multigravidae.
 In the control group - 66% were primigravidae; 34 % were multigravidae
In a similar study by Sharma et al, 2005, the primigravidae constituted to the majority 58% and 
the rest were multigravidae.
Period of gestation
In  our  study,  the  patients  with  term gestation  between  37  –  42  weeks  were  selected  and 
randomised. The preterm labour & the post term pregnancies were excluded from the study.
The mean age of gestation was 39.3weeks in the study group & 39.16 weeks in the control 
group.
In a similar study by Sharma et al, 2005, the mean age of gestation in group A and group B 
were 38.78 weeks and 38.54 weeks respectively.
Quantitative parameters
In our study, the patients with Hb < 7.0 gm/dl were excluded.
Patients with hypertension – Blood pressure of more than 140/90 mm Hg were excluded.
The routine urine & blood examinations were normal in the study and the control groups.
Obese patients with BMI of more than 30 were excluded from the study.
Interventions used
200  patients  with  spontaneous  onset  of  labour  were  selected  for  the  study.  Those  with 
ineffective  uterine  contractions  (or)  premature  rupture  of  membranes  received induction  or 
augmentation  of  labour  either  with  artificial  rupture  of  membranes,  oxytocin,  PGE2  gel, 
stripping (or) a combination of these.
Maximum percentage of patients in both the study & the control groups received interventions- 
70% in the study group & 79% in the control group.
Majority of patients in both the study and control groups received augmentation with oxytocin- 
40% in the study group & 48% in the control group.
The both groups were comparable in respect to the interventions used and ‘p’ value was not 
significant.
Birth Weight
Patients  who  delivered  macrosomic  babies,  cut  off  taken  for  this  study  was  3.5  kg,  were 
excluded from the study. Those with SGA babies were also excluded; the cut off taken in our 
study was 2.5 kg.
The mean birth weight of the babies in the study group was 2.84 kg and in the control group 
was 2.88 kg, the both groups being comparable.
This was similar to the large randomized controlled trial done by Sharma et al, 2005 involving 
958 patients where the mean birth weight was 2.9kg in the study group and 2.83 kg in the 
control group.
Comparison of outcome parameters
Changes in Hemoglobin
In our study, Hemoglobin level was measured at admission before delivery and 48 hours after 
the birth of the baby. The hemoglobin was measured using Sahli’s hemoglobinometer in the 
GRH laboratory.
The mean Hb% in the study group
Before delivery - 9.12
After delivery - 8.74
The mean Hb% in the control group
Before delivery - 9.15
After delivery - 8.55
The fall in the Hb% is 0.38 in the study group and 0.6 in the control group. The ‘p’ value is 
0.0001 which is significant.
However in study by Soltani et al, there was no significant change in mean Hb% after birth. It 
was 1.3 in the control group & 1.2 in the study group.
Duration of III Stage of labour
The duration of III stage of labour from the delivery of the baby to the delivery of the placenta 
with its membranes was calculated in seconds using a stop watch.
In our study, in the study group 80% of patients had duration of III stage upto 5 minutes. In the 
control group, 50% had duration of III stage upto 5 minutes.
The mean duration of the third stage of labour in the study group was 3.5 minutes and in the 
control group was 5.3 minutes.
The result  was statistically  significant.  Several  authors had noted similar significance.  In  a 
randomized controlled trial on 200 patients by Shravage et al the mean duration of the III stage 
was 5.02 minutes in the study group and 7.42 minutes in the control group.
In the study by Giacalone et al 2000, a randomized controlled trial involving 500 patients, the 
median value of duration of III stage of labour was 8 minutes in the cord drainage group and 15 
minutes in the control group.
Gulati et al, on his study on 200 pregnant women to evaluate placental blood drainage, found a 
significance of mean duration of 5.72 minutes in the control group and 2.94 minutes in the 
study group.
Sharma et al on his randomized controlled trial involving 958 women concluded that the mean 
duration of third stage of labour was 3.24 minutes and 3.2 minutes in the placental drainage 
group in contrast to 8.57 minutes and 6.2 minutes in no drainage group in primigravida and 
multigravida respectively, which was of statistical significance. 
Blood Loss
In our study, collecting the blood on to a clean metal bowl, taking care not to include the blood 
from cord drainage, assessed the blood losses. Great efforts were taken to measure the blood 
loss carefully, by using separate mops for episiotomy wounds, but the measurement remained 
open to inaccuracies due to inclusion of some amount of amniotic fluid and omission of some 
blood that can spatter on to the gowns and drapes. This could especially affect the measurement 
of blood loss. However the likely measurement error should be random and would therefore 
reduce the power, but not bias the result. 
The major confounding factor in such studies could be the variation in practice of the use of 
oxytocic drugs both in relation to the type of drug used and the timing of its administration. 
This issue might have a significant effect on the duration and successful completion of the third 
stage of labour.
It was avoided in our study by the practice of active management in all cases in both the study 
and the control groups who received uterotonics at the delivery of the anterior shoulder of the 
baby. Intravenous methergine 0.2mg was given.
Similarly the timing of cord clamping may also confound the result in terms of the duration of 
III stage. Fortunately in our study, all patients in both the groups had immediate clamping of 
the cord (or) within 30 seconds after birth.
Early clamping of the cord would deprive the babies of a natural source of extra blood volume, 
from which they could otherwise benefit. 
The  Hinching brooke  trial  by  Rogers  showed a  higher  mean birth  weight  of  babies  in  no 
drainage group, which they suggested was probably due to the extra blood received prior to 
delayed cord clamping. 
In our study the mean blood loss was 232.5 ml in the study group & 310.1 ml in the control 
group, ‘p’ value <0.001. The result was comparable to that obtained in various trials.
In the similar study by Gulati et al, the amount of blood lost in the III stage of labour was 
193.63 ml in the study group and 247.59 ml in the control group.
Shravage et al reported that the average blood loss in the study group was 175.05 ml. Average 
blood loss in the control group was 252.05 ml.
Postpartum Haemorrhage
In our study, the post partum haemorrahge was calculated as any blood loss of greater than 500 
ml, in otherwise hemodynamically stable women as per the definition of WHO.
In our study 2% of women in the study group developed post partum haemorrhage & 10% in 
the control group.
The blood losses were 600 ml & 580 ml among the two in the study group. The maximum 
blood loss in the control group was 610 ml. 
Among the controls who developed PPH, 60% were primigravidae, 40% were multigravidae. 
Among the study group all 100% were multigravidae
All  the  patients  who  developed  PPH  were  managed  with  general  measures,  medical 
management  and blood transfusion.  None of  the  patients  required  surgical  management  of 
PPH.
2  patients  in  the  study  group  and  7  patients  in  the  control  group  had  their  postpartum 
haemorrahge arrested with intramuscular 15 methyl PGF2α. The other three patients required 
infusion of 20 units of oxytocin in addition to intramuscular 15 methyl PGF2α to arrest the 
postpartum haemorrahge.  Blood transfusion  was required in  both the  patients  in  the  study 
group and six patients in the control group.
In a similar study by Gulati et al, the incidence of postpartum haemorrhage was 12% in the 
control group and 6% in the study group. There was a statistically significant incidence of PPH 
noted by Shravage et al with 3% in the study group & 10% in the control group.
Manual removal of placenta
In our study, the arbitrary time limit set to interfere in cases of retention of placenta in 30 
minutes. If the placenta was not separated at 30 minutes after birth, manual removal was done. 
In our study, 2% of the study group and 2% of the control group patients underwent manual 
removal of the placenta. One patient of study group had manual removal under GA and the 
other three patients had manual removal under regional anesthesia. 
In a similar study by Soltani et al, 2005 there was no significant difference in manual removal 
of placenta in both the groups. 18/250 patients from the study group and 20/250 patients from 
the control group required manual removal of placenta. The actual percentage is little higher in 
the study because the arbitrary time limit set in this study for placental separation to occur was 
20 minutes.
There were no cases of retained placenta in the randomized controlled trial by Shravage et al.
In contrast, in the study by Gulati et al, on 200 pregnant women, manual removal was observed 
the study group in 4% of in the control group, none in the study group, which was statistically 
significant.
Again, in our study there was no difference in the patients with regard to the parity who had 
retained placenta. The incidence was equal among the primigravidae & multigravidae.
Blood Transfusion
In our study, 5% of the study group & 6% of the control group required blood transfusion, there 
was not any significance between the two groups.
In  a  similar  study  by  Soltani  et  al,  the  requirement  of  blood  transfusion  did  not  differ 
significantly  in  two groups.  None required blood transfusion in the study group and 1/250 
required blood transfusion in the control group. The ‘p’ value was 0.5, hence not significant.
 
SUMMARY                         
S U M M A R Y
200 patients admitted in the labour room at Government Rajaji Hospital between September 
2007 to September 2008 in labour, had spontaneous vaginal delivery, who met the criteria laid 
under inclusion categories, were taken for this prospective comparative study.
They were allocated into two groups of 100 each, group A patients had the placental blood 
drained and group B served as control.
In each group, the duration of III Stage, amount of blood loss, complications of III stage were 
recorded. 
The results of the study were tabulated, analyzed and summarized as follows:-
1. Majority of the patients 85-90% in both the study and the control groups were between 
20-29 years.
2. Two-thirds of the study and the control groups were constituted by primigravidae, rest 
were multigravidae.
3. The mean period of gestational age, in weeks was similar in both the groups 38 - 39 
weeks. 
4. 70% of the study group and 79% of the control group received interventions during 
labour.
5. The mean birth weight among both the groups were comparable -       2.84 kg in the 
cases; 2.88 kg in the controls.
6. The duration of third stage of labour was 3.5 minutes in the study group and 5.3 minutes 
in the control group. The ‘p’ value being < 0.0001 the result was statistically significant.
7. The mean drop in Hb% level was 0.3 gm/dl in the study group and 0.6 gm/dl in the 
control group, this difference was also significant.
8. The mean blood loss in study group was 232.5 ml and 310.1 ml in the control group (p < 
0.0001).
9. The maximum blood loss among the study and the controls were 600 ml and 610 ml 
respectively.
10. The  incidence  of  postpartum haemorrhage  was  2% in  study  group  and  10% in  the 
control group.
11. Analyzing  the  parity  in  incidence  of  PPH,  60%  were  primigravidae,  40%  were 
multigravidae in the controls, whereas all were multigravidae among the cases.
12. None of the patients required surgical management for PPH.
13. The incidence of manual removal of placenta in both the groups was similar.
14. The need for blood transfusion was 5% in the study group and 6% in the control group.
CONCLUSION                       
CO N C L USIO N
1. Placental blood drainage is effective in reducing the duration of III stage of labour.
2. It reduces the mean blood loss during the III stage of labour.
3. The decrease in Hb% is less in the placental drainage group than the control group.
4. The incidence of PPH is decreased with using placental blood drainage. 
5. The need for  medical  and surgical  management  of  PPH is  decreased with placental 
blood drainage on critical evaluation. 
6. The need for manual removal of placenta does not differ significantly.
7. Placental blood drainage is a  simple, safe and non-invasive method of managing the 
third stage of labour, that can be practiced even by midwives and para medical workers 
to reduce the complications of the III stage of labour in rural settings too.
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PROFORMA                            
PR O F O R M A
Case No : Control No :
Name : Date of Admission :
Age :
Address : IP No :
Urban : Rural
Type of cases : Booked / Unbooked
LMP : EDD :
Menstrual History :
Regular / Irregular
Period of Gestation :
Obstetric Code : Gravida Para     Live Abortion
Inclusion criteria
1. Singleton pregnancy.
2. Vertex presentation
3. Gestational Age of 37 weeks (or) more
4. No major medical (or) obstetric complications.
5. Spontaneous vaginal delivery.
Exclusion Criteria:
1. HB < 7 gm / dl
2. History of APH
3. Instrumental delivery
4. Multiple pregnancy
5. Malpresentations
6. Large Baby
7. Polyhydramnios
8. Known coagulation disorders
9. Previous surgeries on the uterus
History :
Relevant past history :
General Examination :
Height Weight Temperature
Anemia Pedal edema
PR BP
CVS RS
Obstetric Examination
P/A
P/V
Maternal Hemoglobin before birth :
Time of Delivery of the Baby :
Mode of Delivery :
Spontaneous / Instrumental
Interventions if any :
Time of separation of placenta with membranes:
Duration of III stage of labour
Total amount of Blood loss
Manual Removal of Placenta : Needed / Not any
Retained placenta (> 30 minutes after birth): Yes / No
Blood transfusion at Birth : Yes / No
Maternal Hemoglobin after birth :\
A B B R E VIATIO NS
Group A - Study Group
Group B - Control Group
U - Urban
R - Rural
B - Booked
UB - Unbooked
LAM - Lactational Amenorrhea
Hb - Hemoglobin
HT - Height
WT - Weight
BMI - Body mass index
PR - Pulse Rate
SBP - Systolic Blood Pressure
DBP    -          Diastolic Blood Pressure
ARM - Artificial Rupture of membranes
Anemia - Present - 1
- Nil - 2
Pedal Edema - Present - 1
- Nil - 2
